The latest news, stories and exciting findings from across the Oxford cancer research community
Rewiring T cell co-receptors to improve the safety of cancer immunotherapy
19 January 2026
A new study from the Dushek and van der Merwe labs in the Sir William Dunn School of Pathology demonstrates a novel strategy to reduce dangerous off-target effects in engineered T cell therapies.
Winners of DPhil in Cancer Science Onco-Innovation Project Sandpit Announced
14 January 2026
Congratulations to the following DPhil in Cancer Science students — Michael Bryan, Eva Hanlon, Raul Cioca, Aglaia Skolariki, Nicole Cianci, Roy Rosman Nathanson, Alexandra Petukhova-Greenstein, Anna Prazmo, and Dylan Muldoon — who have been awarded research funding through the 2025 DPhil in Cancer Science Onco-Innovation Project Sandpit.
New NIHR Oxford Senior Research Fellows named
9 January 2026
Eight mid-career researchers identified as having the potential to become future leaders in translational research have been appointed to the next cohort of NIHR Oxford Senior Research Fellows. Those named include Rubeta Matin, Oxford Research Lead for Dermatology Skin Cancer Clinical Trials, and Dr Sarah Gooding, Cancer Research UK Clinician Scientist based at the Weatherall Institute of Molecular Medicine.
Cancer inequalities: Empowering inclusive cancer research
6 January 2026
A recent article on cancer inequalities - written by Cancer Research UK experts, including Oxford's MRC WIMM Director, Professor KJ Patel - discusses why inclusive research is essential to beat cancer for everyone.
Oxford researchers win first and second place in MRC's 2025 Festive Science Image Competition.
19 December 2025
2nd place was awarded to Nathalie Lövgren, DPhil Student, and Dr Iain Tullis, Senior Postdoctoral Researcher, in the Physics and Biology of FLASH Radiation Research Group at the University of Oxford. Nathalie and Iain's snowflake-inspired image was based on their work investigating a potential new radiation treatment for cancer.
The Translational Histopathology Laboratory achieves Good Clinical Laboratory Practice accreditation.
18 December 2025
The Translational Histopathology Laboratory (THL), part of the Oxford Experimental Cancer Medicine Centre (ECMC), has achieved Good Clinical Laboratory Practice (GCLP) accreditation, marking an important milestone in the delivery of high-quality, standardised tissue analysis for the cancer research community in Oxford.
Kendra Perez-Smith receives Outstanding Contribution to Sustainability Award
18 December 2025
Kendra Perez-Smith, Translational Support Unit (TSU) Manager in the Department of Oncology, has received an Outstanding Contribution to Sustainability Award in recognition of her innovation and leadership in establishing Lab QuTe: a department-wide network designed to reduce the environmental impact of clinical trials.
Oxford-built multi-agent assistant for cancer care to be piloted in collaboration with Microsoft
16 December 2025
Researchers at the University of Oxford have developed TrustedMDT, a multi-agent artificial intelligence (AI) system designed to support medical specialists during cancer treatment planning meetings.
Oxford University and Brazil Ministry of Health Sign Letter of Intent to strengthen cancer care across Brazil
15 December 2025
The Ministry of Health of Brazil and Oxford’s Centre for Immuno-Oncology, part of the Nuffield Department of Medicine, have signed a Letter of Intent establishing a broad collaboration to advance cancer research, innovation and clinical translation. The agreement builds on the UK-Brazil Government Health Partnership signed earlier this year, and reflects a shared commitment to accelerating research that will lead to improvements in cancer care across Brazil.
Is now the time to rethink risk thresholds in cancer referral guidelines?
9 December 2025
A new editorial published in the British Journal of General Practice examines how recent research presents an opportunity to refresh how risk thresholds are applied in national primary care cancer referral guidelines. This article was written by Brian Nicholson, Associate Professor in the Nuffield Department of Primary Care Health Sciences, in collaboration with academic thought-leaders from across the UK and CRUK.
New Study to Investigate How Immunometabolism Shapes Treatment Responses in Pancreatic Cancer
5 December 2025
Keaton Jones, Consultant Hepatobiliary and Pancreatic Surgeon at Oxford University Hospitals NHS Foundation Trust and Senior Clinical Researcher in the Department of Oncology at the University of Oxford, has received a Wellcome Trust Early Career Award to investigate the role of macrophage metabolism in determining therapeutic responses in pancreatic cancer.
BLOG: Patient and Public Involvement in Research
27 November 2025
Are you interested in public engagement with cancer research? Julliet Lwiindi, Oxford Cancer's Public Engagement and Involvement Officer, shares a little about the ways in which you can engage with our Oxford Cancer Patient and Public Involvement (PPI) group.
Professor Sarah Blagden shares cutting-edge precision prevention research at Oxford in new Channel 4 Documentary
21 November 2025
Over the past year, Professor Blagden has been filming for Cancer Detectives: Finding the Cures, a new three-part documentary series from Channel 4 which follows three scientists on the front lines of cancer research across the UK.
World’s first lung cancer prevention vaccine gets £2 million for clinical trial
17 November 2025
People at high risk of lung cancer will soon be able to receive the first-ever experimental vaccine, 'LungVax', designed to prevent the disease, in a world-first clinical trial. The LungVax vaccine carries a series of genetic instructions which train the immune system to recognise tumour antigens on the surface of abnormal lung cells.
PODCAST: Could vaccinations stop people from getting cancer?
12 November 2025
Professor Sarah Blagden discusses novel research approaches to cancer prevention on the Oxford Sparks podcast.
Oxford joins £15.9m national initiative to transform cancer research using live human tissue models
11 November 2025
Oxford scientists are part of a new £15.9 million UK initiative to transform disease research through the development of advanced human tissue models. The INTREPID project will evaluate and optimise the use of live human tumour samples to enhance the accuracy of preclinical research, speed up drug discovery, and reduce dependence on animal testing.
Oxford Oncology at ESMO 2025
4 November 2025
The European Society of Medical Oncology (ESMO) Annual Congress took place on 17th-21st October, showcasing the latest advances and insights from the global oncology community. As Europe’s largest oncology meeting, ESMO brings together thousands of researchers, clinicians, and industry leaders for an exchange of cutting-edge research and clinical innovation. Members of the Department of Oncology were in Berlin to present their research, chair sessions, and network with collaborators from across Europe and beyond. Below are some of the highlights from our department’s contributions to ESMO 2025.
Michael Bryan wins international award at Europe’s largest cancer conference
24 October 2025
Michael - who is a CRUK Oxford Centre DPhil in Cancer Science student, working in the Nuffield Department of Medicine's Centre of Immuno-oncology - has been awarded the Best Poster Prize in CNS Tumours at the 2025 European Society for Medical Oncology (ESMO) Congress.
Professor Sarah Blagden to star in New Landmark Channel 4 Documentary Series 'Cancer Detectives: Finding the Cures'
16 October 2025
Channel 4 today announces 'Cancer Detectives: Finding the Cures', an observational documentary series that will explore the pioneering research that could transform the future of cancer detection, treatment and prevention.
Oxford Cancer Announces 2025 CRIS Cancer Clinical Career Fellows
13 October 2025
Oxford Cancer, together with the CRIS Cancer Foundation, is delighted to announce the appointment of the 2025 CRIS Cancer Postdoctoral Clinical Fellows: Dr Rebecca Ling and Dr Casmir Turnquist. Both Fellows will lead on two distinct projects focused on childhood cancer.